{"id":"W2559773245","doi":"10.18553/jmcp.2016.16233","title":"Duration of Treatment in Prostate Cancer Patients Treated with Abiraterone Acetate or Enzalutamide","year":2016,"lang":"en","type":"article","venue":"Journal of Managed Care & Specialty Pharmacy","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Group for Research in Decision Analysis","funders":"Genentech; Astellas Pharma; Janssen Scientific Affairs; Regeneron Pharmaceuticals; Novo Nordisk; Sanofi; GlaxoSmithKline; Pfizer; Allergan; Bristol-Myers Squibb","keywords":"Abiraterone acetate; Enzalutamide; Medicine; Prostate cancer; Hazard ratio; Internal medicine; Proportional hazards model; Oncology; Docetaxel; Cancer; Urology; Gynecology; Androgen deprivation therapy; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001145066,0.0001399293,0.0004336073,0.001047508,0.0003486167,0.0007152955,0.0004605069,0.000329158,0.001737416],"category_scores_gemma":[0.005115986,0.000203168,0.001026683,0.002006532,0.000144508,0.0004803148,0.0004739946,0.0006326986,0.000139101],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008960826,"about_ca_system_score_gemma":0.0009010286,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.005394559,"about_ca_topic_score_gemma":0.007839594,"domain_scores_codex":[0.9987428,0.0002877162,0.0002311077,0.0002816566,0.000313278,0.0001436021],"domain_scores_gemma":[0.9941606,0.000961672,0.00405259,0.0001111486,0.000188778,0.0005251876],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0012824,0.00006590537,0.9951388,0.00004950822,0.0001775882,0.00004883767,0.0000605748,0.0001165025,0.0000780304,0.0000210541,0.0001648256,0.002795945],"study_design_scores_gemma":[0.00008245012,0.0004460528,0.9976667,0.00003906557,0.0001586857,0.0002634622,0.0001528895,0.0003486242,0.0000619685,0.00003768838,0.0007337484,0.000008520185],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9956658,0.00155145,0.00007524464,0.00007679503,0.000009792618,0.00002980935,0.002033716,0.000003146894,0.0005542224],"genre_scores_gemma":[0.9975127,0.0004293305,0.0001249774,0.000066399,0.00002064202,0.00004703896,0.001654521,0.000002838363,0.0001415322],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005394559,"threshold_uncertainty_score":0.01072627,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03042328370747812,"score_gpt":0.3432578116156167,"score_spread":0.3128345279081386,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}